Literature DB >> 15682471

Presence of CCK-A, B receptors and effect of gastrin and cholecystokinin on growth of pancreatobiliary cancer cell lines.

Jin-Young Jang1, Sun-Whe Kim, Ja-Lok Ku, Yong-Hyun Park, Jae-Gahb Park.   

Abstract

AIM: To investigate the effects of gastrin and cholecystokinin (CCK) and their specific antagonists on the growth of pancreatic and biliary tract cancer cell lines.
METHODS: Five pancreatic and 6 biliary cancer cell lines with 2 conrtol cells were used in this study. Cell proliferation study was done using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) test and direct cell count method. Reverse transcription-polymerase chain reaction (RT-PCR) and slot blot hybridization were performed to examine and quantify the expression of hormonal receptors in these cell lines.
RESULTS: SNU-308 showed a growth stimulating effect by gastrin-17, as did SNU-478 by both gastrin-17 and CCK-8. The trophic effect of these two hormones was completely blocked by specific antagonists (L-365, 260 for gastrin and L-364, 718 for CCK). Other cell lines did not respond to gastrin or CCK. In RT-PCR, the presence of CCK-A receptor and CCK-B/gastrin receptor mRNA was detected in all biliary and pancreatic cancer cell lines. In slot blot hybridization, compared to the cell lines which did not respond to hormones, those that responded to hormones showed high expression of receptor mRNA.
CONCLUSION: Gastrin and CCK exert a trophic action on some of the biliary tract cancers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15682471      PMCID: PMC4250587          DOI: 10.3748/wjg.v11.i6.803

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  43 in total

1.  Transfected cholecystokinin receptors mediate growth inhibitory effects on human pancreatic cancer cell lines.

Authors:  K Detjen; M C Fenrich; C D Logsdon
Journal:  Gastroenterology       Date:  1997-03       Impact factor: 22.682

2.  The human gastrin/cholecystokinin receptors: type B and type C expression in colonic tumors and cell lines.

Authors:  P Biagini; G Monges; V Vuaroqueaux; D Parriaux; J F Cantaloube; P De Micco
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

3.  Response to exogenous cholecystokinin of six human gastrointestinal cancers xenografted in nude mice.

Authors:  C Hudd; M C LaRegina; J E Devine; D C Palmer; D R Herbold; M C Beinfeld; F B Gelder; F E Johnson
Journal:  Am J Surg       Date:  1989-04       Impact factor: 2.565

4.  Establishment of a new human pancreatic adenocarcinoma cell line, MDAPanc-3.

Authors:  M L Frazier; S Pathak; Z W Wang; K Cleary; S E Singletary; M Olive; B Mackay; P A Steck; B Levin
Journal:  Pancreas       Date:  1990       Impact factor: 3.327

5.  Cholecystokinin receptors and PANC-1 human pancreatic cancer cells.

Authors:  J P Smith; C A Rickabaugh; P J McLaughlin; I S Zagon
Journal:  Am J Physiol       Date:  1993-07

6.  The Whipple resection for cancer in U.S. Department of Veterans Affairs Hospitals.

Authors:  T P Wade; A G el-Ghazzawy; K S Virgo; F E Johnson
Journal:  Ann Surg       Date:  1995-03       Impact factor: 12.969

7.  Trophic effects of gastrin on colorectal neoplasms in the rat.

Authors:  D B McGregor; R D Jones; D A Karlin; M M Romsdahl
Journal:  Ann Surg       Date:  1982-02       Impact factor: 12.969

8.  Effects of acute and chronic administration of secretin and caerulein on rat duodenal and gastric growth.

Authors:  J Morisset; P Génik
Journal:  Regul Pept       Date:  1983-01

Review 9.  Cholecystokinin receptors.

Authors:  S A Wank
Journal:  Am J Physiol       Date:  1995-11

10.  Autocrine stimulation of growth of AR4-2J rat pancreatic tumour cells by gastrin.

Authors:  M Blackmore; B H Hirst
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

View more
  4 in total

Review 1.  Gastrointestinal hormones regulating appetite.

Authors:  Owais Chaudhri; Caroline Small; Steve Bloom
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

2.  Construction and evaluation of anti-gastrin immunogen based on P64K protein.

Authors:  Xiang-Hua Xiong; Hong-Liang Zhao; Chong Xue; Wei Zhang; Bing-Fen Yang; Xue-Qin Yao; Zhi-Min Liu
Journal:  World J Gastroenterol       Date:  2006-04-07       Impact factor: 5.742

3.  Diagnosis of pernicious anemia and the risk of pancreatic cancer.

Authors:  Pari Shah; Andrew D Rhim; Kevin Haynes; Wei-Ting Hwang; Yu-Xiao Yang
Journal:  Pancreas       Date:  2014-04       Impact factor: 3.327

4.  Using proton pump inhibitors increases the risk of hepato-biliary-pancreatic cancer. A systematic review and meta-analysis.

Authors:  Wence Zhou; Xinlong Chen; Qigang Fan; Haichuan Yu; Wenkai Jiang
Journal:  Front Pharmacol       Date:  2022-09-14       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.